Brenda Mai

Brenda Mai

Auto-generated profile, based on publicly available information

Brenda Mai

Department of Pathology and Laboratory Medicine The University of Texas Health Science Center at Houston, McGovern Medical School Houston Texas USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2021 in Cancers
Verified
Journal Article
Open access
PDF file
ZHZhihong Hu
Zhihong Hu
ZPZenggang Pan
Zenggang Pan
WCWeina Chen
Weina Chen
YSYang Shi
Yang Shi
WWWei Wang
Wei Wang
SHShimin Hu
Shimin Hu
Primary effusion lymphoma (PEL) is a rare type of large B-cell lymphoma associated with human herpesvirus 8 (HHV8) infection. Patients with PEL usually present with an effusion, but occasionally with an extracavitary mass. In this study, we reported a cohort of 70 patients with PEL: 67 men and 3 women with a median age of 46 years (range 26–91). Of these, 56 (80%) patients had human immunodeficiency virus (HIV) infection, eight were HIV-negative, and six had unknown HIV status. Nineteen (27%) patients had Kaposi sarcoma. Thirty-five (50%) patients presented with effusion only, 27 (39%) had an extracavitary mass or masses only, and eight (11%) had both effusion and extracavitary disease. The lymphoma cells showed plasmablastic, immunoblastic, or anaplastic morphology. All 70 (100%) cases were positive for HHV8. Compared with effusion-only PEL, patients with extracavitary-only PEL were younger (median age, 42 vs. 52 years, p = 0.001), more likely to be HIV-positive (88.9% vs. 68.6%, p = 0.06) and EBV-positive (76.9% vs. 51.9%, p = 0.06), and less often positive for CD45 (69.2% vs. 96.2%, p = 0.01), EMA (26.7% vs. 100%, p = 0.0005), and CD30 (60% vs. 81.5%, p = 0.09). Of 52 (50%) patients with clinical follow-up, 26 died after a median follow-up time of 40.0 months (range 0–96), and the median overall survival was 42.5 months. The median OS for patients with effusion-only and with extracavitary-only PEL were 30.0 and 37.9 months, respectively (p = 0.34), and patients with extracavitary-only PEL had a lower mortality rate at the time of last follow-up (35% vs. 61.5%, p = 0.07). The median OS for HIV-positive and HIV-negative patients were 42.5 and 6.8 months, respectively (p = 0.57), and they had a similar mortality rate of 50% at last follow-up. In conclusion, patients presenting with effusion-only versus extracavitary-only disease are associated with different clinicopathologic features. PEL is an aggressive lymphoma with a poor prognosis, regardless of extracavitary presentation or HIV status.

1 December 2019 in Pathology
Verified
Journal Article
Closed access
BMBrenda Mai
Brenda Mai
WWWei Wang
Wei Wang
LML. Jeffrey Medeiros
L. Jeffrey Medeiros
HMHilary Y. Ma
Hilary Y. Ma
ZHZhihong Hu
Zhihong Hu

1 March 2020
Verified
Journal Article
Closed access
BMBrenda Mai
Brenda Mai
CLChristine Liang
Christine Liang
ANAndy Nguyen
Andy Nguyen
AWAmer Wahed
Amer Wahed
LCLei Chen
Lei Chen

1 January 2020 in Academic Pathology
Verified
Journal Article
Open access
PDF file
BMBrenda Mai
Brenda Mai
AWA. Wahed
A. Wahed
LCLei Chen
Lei Chen
NNNghia D. Nguyen
Nghia D. Nguyen
XWXiaohong Iris Wang
Xiaohong Iris Wang
ZHZhihong Hu
Zhihong Hu
The following fictional case is intended as a learning tool within the Pathology Competencies for Medical Education (PCME), a set of national standards for teaching pathology. These are divided into three basic competencies: Disease Mechanisms and Processes, Organ System Pathology, and Diagnostic Medicine and Therapeutic Pathology. For additional information, and a full list of learning objectives for all three competencies, see http://journals.sagepub.com/doi/10.1177/2374289517715040.1

22 March 2026 in American Journal of Case Reports
Verified
Journal Article
Open access
AHAmanda Herrmann
Amanda Herrmann
BMBrenda Mai
Brenda Mai
YBYu Bai
Yu Bai
BCBrian Castillo
Brian Castillo
BKBiswajit Kar
Biswajit Kar
IGIgor D. Gregoric
Igor D. Gregoric
BACKGROUND Acute coronary syndrome is the most common cause of death in the United States. Successful intervention often requires a multi-therapeutic approach, including percutaneous coronary intervention (PCI) and antiplatelet agents such as ticagrelor. However, the use of antiplatelet agents can cause life-threatening bleeding, particularly during emergency procedures. Therapeutic plasma exchange (TPE) is a procedure that selectively removes the patient's plasma to eliminate harmful substances. Here, we present 2 cases of novel TPE implementation in the setting of uncontrolled ticagrelor-induced bleeding. CASE REPORT Our first case was a 52-year-old man who presented with ST-elevation myocardial infarction. He underwent emergency percutaneous coronary intervention and was started on dual antiplatelet therapy (aspirin 81 mg/day, and ticagrelor 90 mg twice daily). A post-infarction ventricular septal defect required emergency surgical repair. After the surgery, uncontrolled bleeding persisted despite all conventional treatment methods. Following TPE, the bleeding was controlled, hemostasis was achieved, and platelet function was increased within days. Our second case was a 66-year-old man who received single doses of ticagrelor (180 mg) and eptifibatide (180 mcg/kg) during an attempted PCI. After complication by left main coronary artery dissection, emergency 2-vessel coronary artery bypass surgery was performed. In the immediate postoperative period, TPE was performed for persistent uncontrolled bleeding. Platelet reactivity increased immediately following the procedure; bleeding was stabilized, and no further blood products were required after postoperative day 1. CONCLUSIONS TPE may be an effective novel option for emergency removal of circulating ticagrelor in refractory bleeding cases.

27 November 2025 in Seminars in Diagnostic Pathology
Verified
Journal Article
Closed access
NINourhan Ibrahim
Nourhan Ibrahim
DRDaniel Rivera
Daniel Rivera
JGJanhavi Govande
Janhavi Govande
BMBrenda Mai
Brenda Mai